Work

Preclinical Project Optimus dose escalation of SN-38 pro-drug PCS11T.

Year: 2025

Type: article

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e15023

Authors: David Young, Sian Elizabeth Bigora, Mary Nyberg, Yvonne Madden

Institution: Processa Pharmaceuticals, Inc. (United States)

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410814050

FWCI:

Cites:

Cited by:

Related to: 10